Get the Stockscreener App
23.65
3.35%
-0.82
After Hours:
23.51
-0.14
-0.59%
Precipio Inc stock is traded at $23.65, with a volume of 52,298.
It is down -3.35% in the last 24 hours and down -23.34% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$24.47
Open:
$24.33
24h Volume:
52,298
Relative Volume:
0.43
Market Cap:
$42.34M
Revenue:
$25.83M
Net Income/Loss:
$-922.00K
P/E Ratio:
-45.84
EPS:
-0.5159
Net Cash Flow:
$555.00K
1W Performance:
-10.62%
1M Performance:
-23.34%
6M Performance:
-13.18%
1Y Performance:
+32.34%
1-Day Range:
$23.45
$24.62
1-Week Range:
$23.23
$27.04
52-Week Range:
$16.40
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
23.65 | 42.34M | 25.83M | -922.00K | 555.00K | -0.5159 |
TMO
Thermo Fisher Scientific Inc
|
675.00 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
224.49 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
412.56 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.79 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.37 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Precipio Inc Stock (PRPO) Latest News
Understanding Momentum Shifts in (PRPO) - Stock Traders Daily
Precipio, Inc. (PRPO) stock price, news, quote and history - Yahoo Finance UK
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? - theglobeandmail.com
Precipio Inc. (PRPO) Edges Higher to $26.46 as Shares Consolidate Below ResistanceBreakout Stock Alerts - careplusvn.com
Precipio Inc. stock gains on Q2 2026 revenue growth and path to profitability - AD HOC NEWS
Precipio Stock Price Forecast. Should You Buy PRPO? - StockInvest.us
Precipio Inc (NASDAQ: PRPO) Share Price, PRPO Stock News, PRPO Share Price & Updates - kalkine.ca
Precipio Q2FY26 Results: Revenue up 22% YoY to $7 million, turns profitable - scanx.trade
Precipio Q2 2026 Earnings Call: Complete Transcript - Benzinga
Technical Reactions to PRPO Trends in Macro Strategies - Stock Traders Daily
The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Abbott, NLI and Precipio - Yahoo Finance
PRPO Q2 2025 Earnings: Positive EPS of $0.05 Signals a Potential Turnaround PointGuidance Update - dars.gov.et
(PRPO) Volatility Zones as Tactical Triggers - Stock Traders Daily
Precipio Inc. (PRPO) Peer Comparison – Compare with Others - Value Research
Precipio Inc. (PRPO) Key Financial Ratios – Valuation, Profitability & More - Value Research
Precipio Inc. (PRPO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Precipio Inc. (PRPO) Slips 2.36% to $26.85 as Shares Approach Key Support ZoneCall Wall - dars.gov.et
PRPO Q2 2025 Earnings: $0.05 EPS Marks Profitability Milestone as Shares Slip 3.04%EPS Revision Trend - dars.gov.et
Precipio (PRPO) Results Versus Estimates: The Report Supplies Updated Headline Figures in the Available Record; Price Reaction: The Stock Ends Down 1.41% for the Current SessionTangible Book Value - siam.in
Precipio (PRPO) Financial Update: Available Data Shows the Latest Reported Performance under the Current Snapshot - vinanet.vn
Precipio (PRPO) Financial Update: Available Data Shows the Latest Reported Performance under the Current Snapshot; Shares Move Higher 3.47% in the Latest ReadingRevenue Recognition Risk - vinanet.vn
PRPO | Precipio, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong - TradingView
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record R - GuruFocus
Precipio (PRPO) Results Check: The Company Publishes Its Latest Results; Price Reaction: Shares Finish 1.53% Lower in the Available RecordEarnings Quality Analysis - vinanet.vn
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ... - Yahoo Finance
Precipio Inc (PRPO) Stock Price, Trades & News - GuruFocus
Precipio, Inc. Q2 2026 Earnings: Revenue Beats $7.02 Million Record - Sci-Tech Today
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com Australia
Precipio Announces Q2-2026 Financial Results - Knoxville News Sentinel
Q2 2026 Precipio Inc Earnings Call Transcript - GuruFocus
PRPO Looks 118.2% Overvalued on GF Value™ - GuruFocus
Precipio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
(PRPO) Risk Channels and Responsive Allocation - Stock Traders Daily
Precipio 2Q Loss $200,000 >PRPO - moomoo.com
Is Precipio Inc (PRPO) Overvalued Despite Q2 Revenue of $7M? GF Score: 51/100, Valuation Discrepancy of 118.4% - GuruFocus
Precipio Posts Record Quarterly Revenue, Returns to Positive Adjusted EBITDA - Minichart
Form 8K Precipio Inc For: 14 August By Investing.com - Investing.com Australia
Precipio Q2 Revenue Hits Record $7.0 Million, Up 22% Year Over Year - Quiver Quantitative
Form 8K Precipio Inc For: 14 August - Investing.com India
Precipio posts record Q2 revenue $7.0M, returns to positive Adjusted EBITDA - TradingView
Precipio (PRPO) hits record Q2 revenue above $7M and returns to positive Adjusted EBITDA - Stock Titan
Precipio Q2 2026 Earnings Call Transcript - MarketBeat
Precipio Q2 Results: EPS turns to loss of $(0.12), sales up 24% - scanx.trade
Precipio, Inc. 2026: Revenue $7.02M, EPS ($0.12) — 10-Q Summary - TradingView
Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive - TradingView
Precipio, Inc. (PRPO) grows Q2 2026 revenue 24% amid going concern warning - Stock Titan
Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Precipio (PRPO.US) will release its earnings report after market close on August 17. - Moomoo
Precipio Inc (PRPO) Stock News Today - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):